StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVP – Free Report) in a research report sent to investors on Saturday morning. The brokerage issued a hold rating on the stock.
Retractable Technologies Stock Performance
Shares of NYSE RVP opened at $0.70 on Friday. The company has a market cap of $20.99 million, a P/E ratio of -1.30 and a beta of 2.28. Retractable Technologies has a 52-week low of $0.56 and a 52-week high of $1.22. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57. The firm’s fifty day moving average is $0.75 and its two-hundred day moving average is $0.73.
Institutional Investors Weigh In On Retractable Technologies
An institutional investor recently raised its position in Retractable Technologies stock. Renaissance Technologies LLC raised its position in shares of Retractable Technologies, Inc. (NYSE:RVP – Free Report) by 9.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 361,253 shares of the company’s stock after acquiring an additional 31,140 shares during the period. Renaissance Technologies LLC owned approximately 1.21% of Retractable Technologies worth $249,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 7.58% of the stock is currently owned by hedge funds and other institutional investors.
Retractable Technologies Company Profile
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
See Also
- Five stocks we like better than Retractable Technologies
- Differences Between Momentum Investing and Long Term Investing
- Why NVIDIA Stock Could Soar Despite Wall Street Downgrades
- Upcoming IPO Stock Lockup Period, Explained
- Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold
- What is a Low P/E Ratio and What Does it Tell Investors?
- 3 Hot New IPOs Defying the 2025 Market Slump
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
